Ikarian Capital »

Sellas Life Sciences Group I shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 355k 14.76
2021-03-31 $410k 48k 8.53

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Sellas Life Sciences Group I

BlackRock
Susquehanna International
State Street Corporation
Vanguard Capital Management
Frigate Ventures
Citadel Advisors
Geode Capital Management
Jones Financial Companies, L.L
Vanguard Portfolio Management
Northern Trust
Perceptive Advisors
Jane Street
Morgan Stanley
Vanguard Fiduciary Trust
UBS Group

View all funds holding Sellas Life Sciences Group I